JP2010517991A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010517991A5 JP2010517991A5 JP2009547779A JP2009547779A JP2010517991A5 JP 2010517991 A5 JP2010517991 A5 JP 2010517991A5 JP 2009547779 A JP2009547779 A JP 2009547779A JP 2009547779 A JP2009547779 A JP 2009547779A JP 2010517991 A5 JP2010517991 A5 JP 2010517991A5
- Authority
- JP
- Japan
- Prior art keywords
- condition
- composition
- compound
- composition according
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 102000003676 Glucocorticoid Receptors Human genes 0.000 claims 2
- 108090000079 Glucocorticoid Receptors Proteins 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- -1 2-methylpyridin-3-yl Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88798107P | 2007-02-02 | 2007-02-02 | |
| PCT/IB2008/000249 WO2008093236A1 (en) | 2007-02-02 | 2008-01-28 | Tricyclic compounds and their use as glucocorticoid receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010517991A JP2010517991A (ja) | 2010-05-27 |
| JP2010517991A5 true JP2010517991A5 (enExample) | 2010-09-24 |
| JP4579333B2 JP4579333B2 (ja) | 2010-11-10 |
Family
ID=39887754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009547779A Expired - Fee Related JP4579333B2 (ja) | 2007-02-02 | 2008-01-28 | 三環式化合物およびそれらのグルココルチコイド受容体調節剤としての使用 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2114888B1 (enExample) |
| JP (1) | JP4579333B2 (enExample) |
| AP (1) | AP2411A (enExample) |
| AT (1) | ATE487700T1 (enExample) |
| AU (1) | AU2008211622B2 (enExample) |
| BR (1) | BRPI0807121A2 (enExample) |
| CA (1) | CA2676907C (enExample) |
| DE (1) | DE602008003405D1 (enExample) |
| DK (1) | DK2114888T3 (enExample) |
| EA (1) | EA016001B1 (enExample) |
| HR (1) | HRP20100726T1 (enExample) |
| IL (1) | IL200044A (enExample) |
| MX (1) | MX2009008286A (enExample) |
| NZ (1) | NZ578661A (enExample) |
| PL (1) | PL2114888T3 (enExample) |
| SI (1) | SI2114888T1 (enExample) |
| UZ (1) | UZ4378C (enExample) |
| WO (1) | WO2008093236A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY153057A (en) * | 2007-02-02 | 2014-12-31 | Pfizer Prod Inc | Tryclic compounds,compositions and methods |
| CN102112446B (zh) * | 2008-07-28 | 2012-10-31 | 美国辉瑞有限公司 | 菲酮化合物、组合物及方法 |
| US20120238549A1 (en) * | 2011-03-15 | 2012-09-20 | Abbott Laboratories | Nuclear Hormone Receptor Modulators |
| WO2013040233A1 (en) * | 2011-09-13 | 2013-03-21 | New York University | Controlling regulatory t cell function |
| TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
| WO2014094357A1 (en) | 2012-12-21 | 2014-06-26 | Abbvie Inc. | Heterocyclic nuclear hormone receptor modulators |
| CN108368094B (zh) * | 2015-09-15 | 2021-07-02 | 利奥制药有限公司 | 用于局部药物递送的非甾体类糖皮质激素受体调节剂 |
| JP7515481B2 (ja) | 2018-12-19 | 2024-07-12 | レオ ファーマ アクティーゼルスカブ | Ｉｌ－１７の小分子調節物質としてのアミノ酸アニリド |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA007483B1 (ru) * | 1999-04-30 | 2006-10-27 | Пфайзер Продактс Инк. | Применение модулятора рецепторов глюкокортикоидов и агониста рецепторов глюкокортикоидов при получении лекарственного средства |
| JP4738603B2 (ja) * | 2000-11-06 | 2011-08-03 | ライオン株式会社 | 歯ブラシ |
| IL146057A (en) * | 2000-10-27 | 2007-09-20 | Pfizer Prod Inc | A process for the preparation of modulators of a non-steroidal glucocorticoid receptor |
| ATE327974T1 (de) * | 2000-10-28 | 2006-06-15 | Pfizer Prod Inc | Modulatoren des glucocorticoid-rezeptors |
| AU2004289532A1 (en) * | 2003-11-13 | 2005-05-26 | Pfizer Products Inc. | Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators |
| EP2012796A4 (en) * | 2006-05-02 | 2010-08-11 | Corcept Therapeutics Inc | USE OF GLUCOCORTICOID TYPE II RECEPTOR ANTAGONISTS TO TREAT PATIENT DEPRESSION WITH IL-2 |
-
2008
- 2008-01-28 PL PL08702358T patent/PL2114888T3/pl unknown
- 2008-01-28 SI SI200830124T patent/SI2114888T1/sl unknown
- 2008-01-28 UZ UZ0900241A patent/UZ4378C/xx unknown
- 2008-01-28 AU AU2008211622A patent/AU2008211622B2/en not_active Ceased
- 2008-01-28 HR HR20100726T patent/HRP20100726T1/hr unknown
- 2008-01-28 JP JP2009547779A patent/JP4579333B2/ja not_active Expired - Fee Related
- 2008-01-28 NZ NZ578661A patent/NZ578661A/en not_active IP Right Cessation
- 2008-01-28 BR BRPI0807121-7A2A patent/BRPI0807121A2/pt not_active Application Discontinuation
- 2008-01-28 DK DK08702358.6T patent/DK2114888T3/da active
- 2008-01-28 CA CA2676907A patent/CA2676907C/en not_active Expired - Fee Related
- 2008-01-28 AT AT08702358T patent/ATE487700T1/de active
- 2008-01-28 EA EA200970662A patent/EA016001B1/ru not_active IP Right Cessation
- 2008-01-28 AP AP2009004941A patent/AP2411A/xx active
- 2008-01-28 DE DE602008003405T patent/DE602008003405D1/de active Active
- 2008-01-28 EP EP08702358A patent/EP2114888B1/en active Active
- 2008-01-28 MX MX2009008286A patent/MX2009008286A/es active IP Right Grant
- 2008-01-28 WO PCT/IB2008/000249 patent/WO2008093236A1/en not_active Ceased
-
2009
- 2009-07-23 IL IL200044A patent/IL200044A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010517990A5 (enExample) | ||
| JP2010517991A5 (enExample) | ||
| JP2010533203A5 (enExample) | ||
| JP2011037901A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2011513196A5 (enExample) | ||
| JP2009530283A5 (enExample) | ||
| ATE531711T1 (de) | Für die behandlung von autoimmunerkrankungen und entzündlichen erkrankungen geeignete tetrahydrocyclopentaäbüindol-3- ylcarbonsäurederivate | |
| JP2009535462A5 (enExample) | ||
| JP2010504286A5 (enExample) | ||
| JP2012522793A5 (enExample) | ||
| JP2009161554A5 (enExample) | ||
| JP2010530897A5 (enExample) | ||
| JP2010535870A5 (enExample) | ||
| JP2012523440A5 (enExample) | ||
| JP2010523692A5 (enExample) | ||
| JP2019501927A5 (enExample) | ||
| JP2016540749A5 (enExample) | ||
| JP2016507581A5 (enExample) | ||
| JP2010536889A5 (enExample) | ||
| JP2010508335A5 (enExample) | ||
| JP2009539848A5 (enExample) | ||
| JP2020500916A5 (enExample) | ||
| CA2676907A1 (en) | Tricyclic compounds and their use as glucocorticoid receptor modulators | |
| JP2010521516A5 (enExample) |